Concepedia

Islam Eljilany

IE

Statistics

Publications

5

Citations

65

H-Index

5

Active since

2021

Affiliations

Moffitt Cancer Center(Current)

The Ohio State University

Huntsman Cancer Institute

University of Utah

University of Iowa

Islam Eljilany is an author at Moffitt Cancer Center specializing in oncology, hypoxic gene expression, and hypoxia adaptation.

ORCID

Publications per year

2021–2024

5

Publications

5

The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer

Martin Benej, Rebecca Hoyd, McKenzie Kreamer et al. · Cancer Research Communications · 2024 · 23 citations · Full text

, , +17

The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

Caroline E. Dravillas, Samuel S. Coleman, Rebecca Hoyd et al. · Cancer Research Communications · 2024 · 12 citations · Full text

, , +17

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature

M. R. SALEM, Islam Eljilany, Ahmed El‐Bardissy et al. · Pharmacogenomics and Personalized Medicine · 2021 · 10 citations · Full text

, , +13

The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors

Islam Eljilany, Payman Ghasemi Saghand, James L. Chen et al. · Cancers · 2023 · 10 citations · Full text

, , +17

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

Ahmad A. Tarhini, Zeynep Eroglu, Islam Eljilany et al. · Clinical Cancer Research · 2024 · 10 citations · Full text

, , +17

1–5 of 5